Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Scopolamine withdrawal syndrome.

K Saxena¹, S Saxena

¹Department of Emergency Medicine, St. Paul-Ramsey Medical Center, MN 55101.

Postgraduate Medicine

|January 1, 1990

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

INVESTIGATING THE EFFECT OF NICOTINE FROM CIGARETTES ON THE GROWTH OF ABDOMINAL AORTIC ANEURYSMS: REVIEW.

Georgian medical news·2024

Same author

<sup>1</sup>H, <sup>13</sup>C, and <sup>15</sup>N backbone chemical shift assignments of coronavirus-2 non-structural protein Nsp10.

Biomolecular NMR assignments·2020

Same author

Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)·2020

Same author

<sup>1</sup>H, <sup>13</sup>C, and <sup>15</sup>N backbone chemical shift assignments of the apo and the ADP-ribose bound forms of the macrodomain of SARS-CoV-2 non-structural protein 3b.

Biomolecular NMR assignments·2020

Same author

Correction to 'Experiential contributions to social dominance in a rat model of fragile-X syndrome'.

Proceedings. Biological sciences·2018

Same author

Experiential contributions to social dominance in a rat model of fragile-X syndrome.

Proceedings. Biological sciences·2018

Transdermal scopolamine effectively prevents motion sickness during travel. However, prolonged use beyond three days can lead to significant withdrawal symptoms, as seen in a recent patient case.

Area of Science:

Pharmacology
Travel Medicine
Neurology

Background:

Transdermal scopolamine is widely used for motion sickness prevention in air and sea travel.
Its application has become a common practice among travelers, particularly on ships.

Observation:

A case study details a patient experiencing withdrawal symptoms.
The patient's symptoms arose after using transdermal scopolamine for longer than the recommended 3-day period.

Findings:

Prolonged transdermal scopolamine use can precipitate withdrawal phenomena.
This highlights potential risks associated with exceeding recommended treatment durations.

Implications:

Clinicians should be aware of potential withdrawal symptoms from transdermal scopolamine.

Related Experiment Videos

Patient education on appropriate use and duration is crucial to mitigate adverse effects.